Live Breaking News & Updates on Intech Biopharm Corp

Stay updated with breaking news from Intech biopharm corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Intech testing new asthma inhaler with eye on US market

Intech Biopharm Corp (益得生技) has started testing the effects of a metered-dose inhaler generic of Teva Pharmaceutical Industries Ltd’s ProAir, and expects to gain marketing approval by 2023, it said yesterday.
The company, which developed SYN011 to treat acute asthma, received approval from the US Food and Drug Administration in August to study the biochemical and physiological effects of the drug in a phase 3 clinical trial, Intech spokesperson Hugues Hung (洪堯國) told the Taipei Times.
The company has recruited about 200 participants with asthma for the test, dividing them into control and experiment groups to receive a placebo, a brand name ....

T Ai Pei , Teva Proair , Peter Lin , Cipla Ltd , Intech Biopharm Corp , Merck Sharp Dohme Ltd , Taipei Exchange On , Taipei Times , Lupin Ltd , Teva Pharmaceutical Industries Ltd Proair , Kao Shih Ching , Biopharm Corp , Teva Pharmaceutical Industries Ltd , Drug Administration , Hugues Hung , Taipei Exchange , India Based Cipla Ltd , Merck Sharp , Dohme Ltd , The Taipei Times ,